Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions.

about

Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism.

P2860

Q54261265-3D6FF1E5-85BE-424E-9C8E-2C9B76F325F4

P2860

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions.

Item

http://www.wikidata.org/entity/Q38645728

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions.

@en

type

Item

label

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions.

@en

prefLabel

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions.

@en

P1476

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions

@en

P2093

Caspar Franck

http://www.w3.org/2001/XMLSchema#string

Katrin Bose

http://www.w3.org/2001/XMLSchema#string

Meike N Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Global cancer statistics, 2012

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Gastric cancer - clinical and epidemiological aspects.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.

Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study.

Leukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study.

P304

5651903

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/5651903

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Marino Venerito

Ali Canbay

Alexander Link

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28785280

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

5530426

http://www.w3.org/2001/XMLSchema#string

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions.

about

P2860

P2860

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932